EGM
KRTX

Engineers Gate Manager’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Engineers Gate Manager’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,384
Closed -$951K – 2148
2023
Q2 		$951K Buy
+4,384
New +$939K 0.04% 719
2023
Q1 		– Sell
-3,028
Closed -$595K – 2097
2022
Q4 		$595K Sell
3,028
-8,565
-74% -$1.84M 0.04% 781
2022
Q3 		$2.61M Buy
11,593
+9,263
+398% +$1.87M 0.16% 133
2022
Q2 		$295K Buy
2,330
+310
+15% +$35.6K 0.01% 1433
2022
Q1 		$256K Buy
+2,020
New +$227K 0.01% 1497

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Engineers Gate Manager's KRTX Position: Q3 2023 in Review

Engineers Gate Manager sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 4,384 shares — an estimated $951K sold.

Engineers Gate Manager first reported a position in KRTX in Q1 2022 and held it in 5 quarters. The position peaked at $2.61M in Q3 2022. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

  • Engineers Gate Manager reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Engineers Gate Manager sold 4,384 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $951K.
  • Engineers Gate Manager first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Engineers Gate Manager's Karuna Therapeutics, Inc. Common Stock position peaked at $2.61M in Q3 2022.
  • 256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Engineers Gate Manager's 13F filing for Q3 2023, filed 14 Nov 2023.